Head pain is not a small problem. Headache disorders affected about 2.9 billion people in 2023, with a global age-standardised prevalence of 34.6%. Migraine alone sat near 14.1% of the world population and still drives most of the disability tied to headache. That is why so many people now look past pills and toward trigeminal nerve stimulation.
Read the Vagus Insider blog guide to trigeminal nerve stimulation devices
What Trigeminal Nerve Stimulation Actually Does?
The trigeminal nerve is the fifth cranial nerve. It carries sensation from the face, scalp, and much of the head. When that pathway stays overactive, pain can flare fast. External trigeminal nerve stimulation (eTNS or e-TNS) sends low-level current through pads or a wearable band on the forehead. The target is usually the supraorbital and related branches.
Research reviews describe several effects that may stack together:
- A shift in pain signaling inside the trigeminal system
- Changes in neuropeptides linked to migraine
- Possible influence on autonomic balance
- A calmer response during an attack, or fewer attacks when used on a schedule
This is not magic. It is neuromodulation. The pulse is small. Most users feel a tingling or tapping on the skin. Intensity can be raised or lowered. If a session stings, the setting is too high.
Why Interest in These Devices Keeps Rising?
Medication helps many people. It also fails many people. Side effects, rebound headache, and limits during pregnancy push families toward non-drug options. Device makers answered with forehead wearables, dual-nerve headsets, and night-use pediatric systems.
A few facts keep the category in the news:
- Headache disorders remain among the most common nervous-system conditions worldwide.
- Migraine still accounts for most years lived with disability among headache types.
- The U.S. Food and Drug Administration cleared external trigeminal nerve stimulation for pediatric ADHD in 2019 as a non-drug option for children ages 7 to 12 who were not on ADHD medicine at the time.
- Separate clearances exist for acute and preventive migraine use of forehead eTNS in adults, depending on the device class and labeling.
The TEAM study of eTNS for acute migraine reported higher two-hour pain freedom with active stimulation than with sham. One published summary put pain freedom near 25.5% in the treatment group versus 18.3% in sham. Another analysis of the same line of work cited about 27% versus 18%. The gap is modest. For people who want fewer drugs, even a modest gap matters.
Types of Trigeminal Nerve Stimulation Devices
Not every unit works the same way. Shoppers who treat every box as identical get disappointed. The market splits into a few clear groups.
Forehead eTNS wearables
These sit across the brow. They are the most common consumer-facing style. A typical session for an attack may run about an hour. Preventive use may be a shorter daily block. They suit people who want a single, visible target and a repeatable routine.
Combined trigeminal and occipital systems
Some headsets reach both the trigeminal branches and occipital nerves at the back of the head. The pitch is wider coverage for severe head and face pain. These units can feel bulkier. They may need a prescription in some regions.
Night-wear pediatric eTNS
One cleared path in ADHD care uses overnight stimulation. The child wears the device during sleep. Families like the “set it and leave it” pattern. Follow-up with a pediatric specialist still matters, because ADHD care is broader than one gadget.
Home wellness units that sit near the same idea
Some products sold for calm, sleep, or general nerve support borrow the language of cranial-nerve stimulation without matching a prescription label. Those units can still feel useful. They should not be sold as a stand-in for a cleared medical device.
How People Use These Devices Day to Day
A typical adult migraine plan looks like this:
- Keep the skin clean and dry.
- Place the electrode or band as the maker shows.
- Start at a low setting.
- Raise intensity until a steady tingle appears, not pain.
- Run the full session without stopping early unless the skin protests.
- Log time of use, pain score, and any medicine taken.
Preventive users often pick a quiet window each day. Acute users start at the first sign of an attack. Consistency beats heroics. One perfect session after three skipped weeks rarely changes the pattern.
The best device is the one a person will actually wear.
What Current Data Shows
Numbers help more than slogans. The table below pulls recent public figures that sit behind this category.
| Measure | Latest figure | Why it matters |
| People with headache disorders (2023) | About 2.9 billion | Shows how large the need is |
| Global age-standardised headache prevalence (2023) | 34.6% | Head pain is common, not rare |
| Global age-standardised migraine prevalence (2023) | 14.1% (higher in females) | Explains demand for drug-free tools |
| Migraine YLDs in 2023 | 40.9 million | Disability stays high even when prevalence looks stable |
| TEAM-style 2-hour pain freedom (active vs sham) | About 25–27% vs 18% | eTNS can help some attacks, not every attack |
| FDA ADHD eTNS clearance | 2019, ages 7–12 | First non-drug device path in that pediatric group |
Sources include the Global Burden of Disease 2023 headache analysis in The Lancet Neurology, WHO headache summaries, FDA device announcements, and published TEAM trial reports.
A 2025 GRADE-style discussion of chronic migraine also listed eTNS among device options when medicine is not enough. Chronic migraine still affects roughly 2% of the general population in many estimates. That group feels the cost of missed work and family time most sharply.
Who May Benefit, and Who Should Pause
eTNS tends to attract:
- Adults with episodic migraine who want a non-drug add-on
- People who cannot tolerate standard abortive medicine
- Families seeking a cleared pediatric ADHD device path
- Users who already like structured, timed self-care
Pause and speak with a clinician first when a person has:
- An implanted electronic device that could clash with electrical stimulation
- Broken or irritated skin on the forehead
- Unexplained new headache that has not been checked
- Pregnancy, unless a clinician has already signed off
- A history of seizures that has not been reviewed for device use
Pregnancy research is moving. A 2025 paper on neuromodulation in pregnancy framed eTNS as a non-drug option under study. A registry also opened to track external trigeminal nerve stimulation for migraine in pregnancy. That is promising. It is not a green light for unsupervised use.
How to Compare Devices Without Getting Lost
Shoppers can score units on a short list.
Fit and comfort. A band that slips off mid-session will not get used.
Session length. Some people will sit for 60 minutes. Many will not.
Acute vs preventive modes. A dual-mode unit saves money and shelf space.
Prescription status. Some systems need a clinician. Others do not.
App and logs. A simple diary helps a person see whether pain days drop.
Skin care. Hypoallergenic pads and replaceable electrodes matter after week three.
Support. Clear instructions beat a glossy box.
Safety, Side Effects, and Realistic Expectations
Most reported effects are local. Tingling. Redness. A brief headache after a first session. Sleepiness in night-wear pediatric use. Serious events are uncommon in published eTNS work, which is why regulators treat many of these units as low-risk compared with surgery.
Still, “low risk” is not “no risk.” Overuse of pads can irritate skin. Too high an intensity can make a person drop the habit. Starting during an unexplained thunderclap headache is the wrong time to experiment.
Results vary. Some users cut attack intensity. Some cut attack days. Some notice little change and move on. That spread is normal in neuromodulation. A four-to-eight-week trial with a pain diary is more honest than a one-night test.
How Trigeminal Tools Sit Next to Vagus Tools
The trigeminal nerve and the vagus nerve are not the same cable. They do share traffic in the brainstem. Animal and human work on non-invasive vagus stimulation has shown reduced trigeminal nociception in migraine models. That crossover is why many wellness buyers keep both styles in one drawer.
A practical split looks like this:
- Forehead eTNS when the main goal is migraine or ADHD-labeled pediatric use
- Neck or ear vagal tools when the main goal is calm, sleep, or autonomic tone
- Combined routines when a person has both head pain and high stress load
Best Trigeminal Nerve Stimulation Devices
| Rank | Device | What it is, who it fits, and how people actually use it |
| 1 | Pulsetto | Pulsetto is a wearable neckband that sends mild electrical pulses through the skin toward the cervical vagus nerve, not a classic forehead trigeminal patch. Vagus Insider still ranks it first for readers who want one daily device that is easy to put on, pair with an app, and use without a clinic visit. The band sits on the neck with electrode pads on each side. Programs commonly include Stress, Calm, Sleep, Focus, Recovery, Release, Gut, and Head, with session lengths from about four minutes to about twenty. Intensity is adjustable. Many users run two or three short sessions a day with a break between them. The pitch is autonomic calm, sleep support, and a “Head” routine that some people add when tension and head discomfort travel together. It is not an FDA-cleared external trigeminal nerve stimulator for migraine or pediatric ADHD. A clinician still needs to clear use when a person has an implant, heart-rhythm issues, or unexplained new pain. Families like the short sessions and the fact that the unit can live next to other nerve tools. Replaceable pads and a snug but comfortable fit decide whether the habit lasts past week one. Consistency matters more than chasing the highest setting. |
| 2 | Cefaly Dual | Cefaly Dual is the best-known dedicated external trigeminal nerve stimulation device for migraine. A small rechargeable module clicks onto a disposable electrode on the forehead and targets supraorbital branches of the trigeminal nerve. Two fixed programs define the routine. The acute program runs about 60 minutes at 100 Hz when an attack starts. The preventive program runs about 20 minutes at 60 Hz and is meant for daily use. Maximum output is listed near 16 mA, with a biphasic pulse around 250 µs. Intensity ramps for roughly the first 14 minutes, so the first part of a session can feel quiet and then build into a tingle. Published TEAM-style work found higher two-hour pain freedom with active stimulation than with sham, though many users still need medicine on hard days. Skin prep and fresh electrodes matter. A second acute session the same day is sometimes used if pain lingers, following the maker’s instructions. This unit is for people who want a forehead device built around migraine, not a general wellness neckband. Redness and tingling are the usual complaints. Anyone with broken forehead skin, an unexplained thunderclap headache, or an incompatible implant should wait for medical advice. |
| 3 | Relivion MG | Relivion MG is a prescription headset that does more than single-site forehead work. It delivers external concurrent occipital and trigeminal neurostimulation (eCOT-NS) through six electrodes: four over trigeminal branches on the brow and two over occipital nerves at the back of the head. The U.S. FDA cleared it for acute migraine treatment. In published sham-controlled work, active use beat sham on pain relief and pain freedom at one hour, two hours, and 24 hours in at least one trial dataset, with figures such as pain-intensity drop of about 53% versus 10% at one hour and complete pain freedom near 46% versus 12% in the clearance narrative. Sessions often run twenty minutes or longer. An app can log treatments and support a clinician review. The headset is bulkier than a slim forehead puck, so comfort and hair, glasses, and pillow position decide whether a person finishes the session. Mild, short-lived side effects were reported more than serious ones. This tool fits adults who want a multi-nerve, in-home acute option after a prescriber signs off. It is not a children’s overnight ADHD device and it is not a four-minute stress gadget. Replacement parts and training on electrode contact are part of real-world use. |
| 4 | Monarch eTNS System | The Monarch external Trigeminal Nerve Stimulation System is the device most closely tied to pediatric ADHD, not migraine branding. The FDA permitted marketing in 2019 for children ages 7 to 12 who were not on ADHD medicine at the time of the original clearance path. A caregiver places a single-use forehead patch over the supraorbital and supratrochlear branches and connects it to a small pulse generator. Therapy runs during sleep for about eight hours. Gen 2 parameters include a symmetrical square wave near 120 Hz, pulse width about 250 µs, and caregiver-adjusted current up to about 8 mA in fine steps. Stimulation cycles rather than blasting nonstop, which helps many children sleep through a light tingle. Imaging work has pointed to frontal networks linked with attention. Nightly use for weeks is the model; four-week trial windows are often cited when families and clinicians review change in symptoms. Patches are disposable, so supply cost is part of the plan. This is prescription-style home care with caregiver setup, not a grab-and-go wellness band. Drowsiness and local skin effects show up more than dramatic adverse events in published summaries. Adult off-label curiosity exists, but the labeled story remains pediatric and overnight. |
| 5 | Truvaga Plus | Truvaga Plus is a handheld cervical transcutaneous vagus nerve stimulator, not a forehead eTNS band. People still put it on “best nerve stimulation” shortlists because non-invasive vagus work can damp trigeminal pain signaling in migraine models, and some handheld cervical units sit in the same shopping basket as prescription nVNS tools. The user holds the device against the side of the neck, often with a conductivity spray, and runs brief sessions measured in minutes rather than an hour. Published cervical nVNS research in headache care is stronger for dedicated medical handhelds than for every consumer look-alike, so a person should read the exact label on the unit in hand. Truvaga-style devices appeal to adults who dislike a full headset, want a pocketable tool, and already think in terms of autonomic tone, stress load, and attack-day support. Intensity is raised until a contraction or tingle is felt without pain. Neck placement must stay off the windpipe and away from irritated skin. This is a poor pick when the only goal is a cleared pediatric ADHD overnight protocol. It is a stronger pick when the household already uses vagal routines and wants a second, portable input. Clinician review still applies with implants or known carotid concerns. |
| 6 | Nurosym | Nurosym is an auricular transcutaneous vagus nerve stimulator. A clip sits on the ear so pulses reach the auricular branch of the vagus, especially regions such as the cymba concha that light up brainstem hubs on imaging. It is not a trigeminal forehead electrode. Buyers include it in wide nerve-stimulation comparisons because ear-based vagal input is portable, discreet, and often studied for heart-rate variability, stress physiology, and autonomic shift. Sessions are typically shorter than a 60-minute acute migraine forehead program. The ear clip must stay on clean skin; poor contact wastes a session. People who already wear glasses, hats, or sleep on one side sometimes prefer ear clips over bulky headsets. Evidence should be read for the outcome the person cares about. Ear-vagus data is not the same file as TEAM eTNS migraine data or Monarch ADHD data. Tingling in the ear, local irritation, and the odd session of lightheadedness are the practical watch-outs. Families looking only for a labeled pediatric ADHD patch should not treat this as a substitute. Adults building a mixed cranial-nerve kit often keep an ear unit beside a forehead unit and log which one they used on high-pain days. |
| 7 | gammaCore Sapphire | gammaCore Sapphire is a prescription non-invasive vagus nerve stimulator held against the neck. It is one of the few handheld neuromodulation tools with a long public record in migraine and cluster headache care, including FDA-cleared uses that changed over time for acute and preventive headache indications. Mechanism is cervical vagus stimulation through the skin, not direct supraorbital trigeminal stimulation. That still matters in a trigeminal article because vagal input can inhibit trigeminal nociception in experimental models and in clinic protocols for primary headache. A typical use pattern is short, timed stimulations at the onset of an attack or on a preventive schedule set with a clinician. Conductive gel or spray and correct neck landmarks decide whether the pulse reaches the target. Insurance, prescription status, and refill of gel supplies shape real cost. This device fits adults already in specialty headache care, not a child who needs an overnight forehead ADHD patch. Side effects discussed in practice include muscle twitch, application-site discomfort, and the need to stop if the sensation is harsh. It is a medical tool with a label, not a wellness gadget with eight lifestyle programs. |
| 8 | Cefaly Enhanced / current Cefaly forehead line | Later Cefaly forehead models keep the same core idea as Dual: one channel, a brow electrode, and separate acute and preventive logic for migraine eTNS. Public technical sheets describe a light module, rechargeable lithium-polymer cell, biphasic rectangular pulses, and program lengths that still cluster around a long attack session and a shorter daily preventive session. Some hardware refreshes change weight, housing, or charging time more than they change the nerve target. The user story stays simple. Clean the forehead. Stick the electrode. Clip the device. Let intensity climb. Sit still. People who already learned Dual usually adapt fast. Electrode subscriptions become the quiet monthly cost. This line remains the cleanest “real tool” answer when someone types best trigeminal nerve stimulation devices and means a forehead migraine wearable with a regulatory history. It will feel too slow for a person who only wants a four-minute neck session before a meeting. It will feel too narrow for a person who wants occipital and trigeminal coverage in one headset. Used as labeled, it is still the reference product clinicians name first when they explain external trigeminal stimulation for migraine. |
| 9 | Relivion-style dual-nerve headsets in clinical follow-on use | After the first Relivion MG clearance story, dual-nerve headsets stayed in the pipeline for head and face pain and for research beyond a single acute migraine visit. The design goal is the same: stimulate trigeminal branches in front and occipital branches behind at once, with adaptive channels and app support. New trial listings have tested combined trigeminal and occipital stimulation for severe head and face pain, which tells readers where the category is going. A person considering this class should ask a clinician three plain questions. Is the exact model cleared for the person’s diagnosis? How long is a session? What happens if skin under six electrodes gets angry after a week? These headsets ask more of hair, comfort, and setup time than a single brow puck. They also give a broader field when pain wraps from eye to occiput. They are the wrong first buy for a parent seeking an eight-hour pediatric ADHD patch or for a commuter who will only wear a neckband on a train. When the pain map is wide, dual-nerve hardware is the honest match. When the pain map is a classic frontal migraine, a simpler eTNS puck may be enough. |
| 10 | Clinical TENS units used on supraorbital points | Some pain clinics and home users still place a standard transcutaneous electrical nerve stimulation unit on supraorbital or other facial points as a low-cost cousin of branded eTNS. This is a real tool category, not a single hero brand. A dual-channel TENS box, small electrodes, and a conservative intensity can mimic the “tingle on the brow” feeling. It is not the same as a migraine-labeled eTNS program with fixed 60 Hz or 100 Hz protocols and a device-specific electrode. Pulse width, rate, and session time vary by unit and by the clinician’s protocol. That flexibility is the appeal and the risk. A person can under-dose, over-dose, or park an electrode on irritated skin. Facial TENS is a poor plan over broken skin, near the eyes without training, or in anyone with an incompatible implant. It can be a bridge when a branded headset is out of reach and a clinician has already mapped safe points. People who want published TEAM or RIME numbers should not pretend a generic TENS file is those trials. People who want a cheap, adjustable, clinic-familiar box sometimes start here, then move to a labeled forehead system if the sensation helps and the routine sticks. |
